Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
EditorialEditorial
Open Access

Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research

Xiaoyu Song, Xiyan Liu, Qiqiang Guo, Hongde Xu and Liu Cao
Cancer Biology & Medicine July 2024, 21 (7) 541-546; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0157
Xiaoyu Song
1The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, China
2Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors of Ministry of Education, Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, China Medical University, Shenyang 110122, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiyan Liu
1The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, China
2Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors of Ministry of Education, Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, China Medical University, Shenyang 110122, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiqiang Guo
1The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, China
2Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors of Ministry of Education, Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, China Medical University, Shenyang 110122, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongde Xu
1The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, China
2Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors of Ministry of Education, Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, China Medical University, Shenyang 110122, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hongde Xu
  • For correspondence: hdxu{at}cmu.edu.cn lcao{at}cmu.edu.cn
Liu Cao
1The College of Basic Medical Science, Health Sciences Institute, China Medical University, Shenyang 110122, China
2Key Laboratory of Cell Biology of Ministry of Public Health, Key Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors of Ministry of Education, Liaoning Province Collaborative Innovation Center of Aging Related Disease Diagnosis and Treatment and Prevention, China Medical University, Shenyang 110122, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Liu Cao
  • For correspondence: hdxu{at}cmu.edu.cn lcao{at}cmu.edu.cn
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    The dual roles of senescent cells in tumor development and progression. The occurrence of aging or therapeutic senescence has dual effects on tumor development and treatment. On the one hand, aging-mediated tumor cell growth arrest functions primarily as a tumor suppressor in early stages of tumor progression. Moreover, components secreted by senescent cells such as IL-6 and IL-8 reinforce the effects of senescence and further inhibit tumor progression (blue arrow). On the other hand, aging of the whole body mediates changes in the tumor environment, thereby aggravating tumor treatment resistance, tumor metastasis, angiogenesis, downstream metastasis, and early remodeling of the micro-environment (red arrow). Notably, senescent fibroblasts secrete components such as IL-6, L-8, AREG, CCL5, CXCL12, OPN, and HGF, which promote tumor cell proliferation, metastasis, and angiogenesis by remodeling the tumor microenvironment through MMPs and VEGF. In metastatic sites, senescent osteoblasts remodel the downstream metastatic microenvironment and promote the seeding and proliferation of circulating tumor cells.

  • Figure 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2

    Cell-fate decisions mediated by intricate molecular crosstalk. At the cellular and molecular levels, multiple signaling pathways and regulatory mechanisms are intertwined in a complex network. Dysregulated signaling cascades, such as the p53-p21 and p16INK4a-Rb pathways, lead to imbalances in the cellular senescence response to various stresses, thereby contributing to malignant transformation. Certain mutations have been shown to delay the aging process but also increase the risk of tumorigenesis. In the process of malignant transformation, cellular homeostasis maintenance mechanisms and epigenetic reprogramming play important roles. The maintenance mechanism of cellular homeostasis is not only key to maintaining biological homeostasis but also serves as barrier to preventing the malignant transformation of cells. However, cancer cells achieve aberrant proliferation and survival by exploiting the vulnerabilities of the aging machinery and escaping the restrictions of the maintenance mechanisms of cellular homeostasis. In addition, senescent cells alter the tumor microenvironment by secreting proinflammatory factors, which further contribute to tumor development and treatment resistance.

  • Figure 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3

    Senescence-based anti-tumor strategies. Inducing the senescence of tumor cells at early stages of tumor development is an effective anti-tumor concept. In late tumor stages, immunosuppression of the microenvironment and various treatment resistance elements are usually alleviated by elimination of senescent cells. Combined multi-disciplinary, multi-omics analyses using multiple technical methods are expected to reveal the intricate relationship between cellular senescence and tumor malignant transformation, and lead to more efficient tumor treatments in the future.

PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 21 (7)
Cancer Biology & Medicine
Vol. 21, Issue 7
15 Jul 2024
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research
Xiaoyu Song, Xiyan Liu, Qiqiang Guo, Hongde Xu, Liu Cao
Cancer Biology & Medicine Jul 2024, 21 (7) 541-546; DOI: 10.20892/j.issn.2095-3941.2024.0157

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research
Xiaoyu Song, Xiyan Liu, Qiqiang Guo, Hongde Xu, Liu Cao
Cancer Biology & Medicine Jul 2024, 21 (7) 541-546; DOI: 10.20892/j.issn.2095-3941.2024.0157
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Cellular senescence: guardians or instigators?
    • Deciphering the molecular crosstalk: insights into malignant transformation
    • Therapeutic implications and future perspectives
    • Conclusions
    • Conflict of interest statement
    • Author contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Chimeric antigen receptor macrophages: a new frontier in hepatocellular carcinoma treatment
  • Advances in antibody-drug conjugates for urothelial carcinoma treatment
  • Progress toward cervical cancer elimination: global disparities and China’s contributions
Show more Editorial

Similar Articles

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire